Sol Gel Technologies Enters into Licence Agreement with Searchlight Pharma

Sol-Gel Technologies and Searchlight Pharma have officially signed exclusive licence agreements for the distribution and commercialisation of TWYNEO and EPSOLAY in the Canadian market. As part of the agreement, Sol-Gel will receive potential upfront payments and milestones totalling up to $11 million for two drugs. These payments may be associated with regulatory approvals and sales milestones. Additionally, Sol-Gel will be entitled to royalty percentages based on the net sales in Canada. The initial term of the agreement spans fifteen years, with the possibility of renewal for subsequent five-year periods. This collaboration aims to make these advanced dermatological treatments widely available to Canadian consumers, addressing their specific skincare needs. TWYNEO and EPSOLAY are two new dermatology products developed by Sol-Gel Technologies. With the signing of these agreements, both companies aim to bring innovative dermatological solutions to patients in Canada. TWYNEO is a combination cream that contains tretinoin (a retinoid) and benzoyl peroxide. It is used for the treatment of acne vulgaris in adults and paediatric patients 9 years of age and older. EPSOLAY is a cream that contains benzoyl peroxide at a concentration of 5 percent. It is specifically indicated for the treatment of inflammatory lesions associated with rosacea in adults.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!